Press Releases

Press Releases

IVI to help developing countries tackle the spread of infectious diseases by building capacity through vaccinology training in Seoul

IVI acquires supplemental funding for Severe Typhoid in Africa Program (SETA Plus)

IVI Director General Dr. Jerome Kim to join the Human Vaccines Project’s Efforts as One of Four Distinguished Global Leaders to Decode the Human Immune System

Prof. Young Chul Sung, biotech leader, personally donates US$8.4 million to IVI

New push to develop world’s first vaccine against the deadly Strep A bacteria killing hundreds of thousand

IVI-led CAPTURA consortium wins Fleming Fund award for work on antimicrobial resistance (AMR) data across Asia

IVI receives $15.7 million grant to conduct phase III trials of new Vi-DT typhoid conjugate vaccine manufactured by SK bioscience of Korea

‘IVI Forum for Enhancement of Cooperation’ hosted jointly by the Korean Parliamentary Forum for Global Health, and KCDC under MOHW

Vaccine study confirms sensitivity of cholera test

Korean Pediatric Association, IVI, KSC exchange MOU

IVI receives $3.2 million grant to support TCV effectiveness studies in West Africa

CEPI partners with IVI to accelerate development of vaccines against emerging global health threats

Henry Lau joins IVI as Goodwill Ambassador

Nature Communications study addresses MDR typhoid

THSTI, IVI held joint symposium on Nov. 22

‘The Euvichol story’ published in Vaccine

IVI accelerates development of MERS vaccine

IVI’s 18th Vaccinology Course gathers 120 international participants from 19 countries in Seoul September 3-7

KOICA, IVI team up with Mozambican MoH and INS, partners to vaccinate 190,000 people against cholera

IVI acquires $5 million grant to support process development, scale up of typhoid conjugate vaccine with SK Bioscience

×

2015 Shinil-IVI Global Vaccine Forum: Int'l MERS-CoV Symposium on September 10, 2015

Author
ivi
Date
2016-10-10 02:13
Views
1435

 


 



 


 


2015 Shinil-IVI Global Vaccine Forum:


 


International MERS-CoV Symposium


 


10th September 2015


 


Champagne Hall, Novotel Ambassador Gangnam, Seoul, Republic of Korea


 


Agenda


 



Overview: Scientists from the Republic of Korea, East Asia, Middle East, United States and Europe will present the latest translational and clinical research data, and discuss research opportunities related to Middle East Respiratory Syndrome (MERS), an emerging viral disease caused by Middle East Respiratory Syndrome Coronavirus (MERS-CoV) that is responsible for severe acute respiratory infection in more than 1,000 people across 25 countries. The need for vaccine development will be discussed as zoonotic outbreaks are likely to happen again and could lead to more serious epidemics.


 


 


 


08.30-09.00           Registration / Refreshments


 


 


 



 



OPENING REMARKS


 


09.00-09.10          Dr. Jerome Kim, Director General, International Vaccine Institute (IVI)


 


09.10-09.20          Prof. Wan-Kyoo Cho, Executive Advisor, Korea Support Committee for IVI


 


 


 



 



SESSION 1: Surveillance and Epidemiologic Investigation


 


Moderator                Dr. Youngmee Jee (Korea National Institute of Health) and


 


                                  Prof. Joon-Haeng Rhee (Chonnam National University Medical School, Korea)


 


                          


 


09.20-09.40          Evolution of the MERS-CoV Outbreak in the Republic of Korea


 


                           Dr. Jerome Kim, International Vaccine Institute


 


                          


 


09.40-10.00          Challenges and Successes in Controlling MERS-CoV in the Kingdom of Saudi Arabia


 


Dr. Abdulaziz Abdullah Bin Saeed, Ministry of Health, Kingdom of Saudi Arabia


 


 


 


10.00-10.20          The Role of International Normative Bodies in Anticipating Outbreaks


 


Dr. Kayvon Modjarrad on behalf of WHO, Walter Reed Army Institute of Research, USA


 


 


 


10.20-10.40          Q&A


 


 


 


10.40-11.00          Break / Press Conference


 


 


 



 



SESSION 2: Vaccines and Monoclonal Antibodies


 


Moderator                Prof. Baiklin Seong (Yonsei University, Korea) and


 


                                  Dr. Laura Digilio (International Vaccine Institute)


 


 


 


11.00-11.20          An Integrated Approach to Developing MERS-CoV Vaccines and mAbs


 


                           Dr. Kayvon Modjarrad, Walter Reed Army Institute of Research, USA


 


 


 


11.20-11.40          A Spike Nanoparticle MERS-CoV Vaccine


 


Mr. Russell P. Wilson, Novavax, USA


 


 


 


11.40-12.00          DNA Vaccine for MERS-CoV


 


                           Dr. Scott White, Inovio Pharmaceuticals, USA


 


 


 


12.00-12.10         Clinical Development of a DNA-based MERS Vaccine: Opportunities and Challenges


 


                           Dr. Joel Maslow, GeneOne Life Science, Inc., Korea


 


 


 


12.10-12.30          Q&A


 


 


 


 


 



 



KEYNOTE SPEECH


 


12.30-12.45          H.E. Mark W. Lippert, U.S. Ambassador to the Republic of Korea, Embassy of the United States, Seoul


 


 


 


12.45-12.55          Group Photo


 


 


 


12.55-14.00          Lunch at The Square 


 


 


 



 



SESSION 3: Diagnostics and Therapeutics


 


Moderator                Prof. Daesub Song (Korea University, Korea) and


 


                                  Dr. In Kyu Yoon (International Vaccine Institute)


 


 


 


14.00-14.20         Identification of Potent Neutralizing Antibodies against MERS-CoV


 


                           Dr. Christos Kyratsous, Regeneron, USA


 


 


 


14.20-14.40          Use of Diagnostics to Aid in Identification of MERS-CoV Cases


 


                           Dr. Susan Gerber, Centers for Disease Control and Prevention, USA


 


 


 


14.40-15.00          Developing Viral Fusion Inhibitors for Prevention and Treatment of MERS-CoV Infection


 


Prof. Shibo Jiang, Fudan University, China


 


 


 


15.00-15.20          MERS-CoV: Opportunity for Drug Discovery in Korea to Complement Vaccine Development


 


Dr. Ji-Young Min, Institut Pasteur Korea, Korea  


 


 


 


15.20-15.40          Q&A


 


 


 


15.40-16.00          Break


 


 


 



 



SESSION 4: Clinical Considerations and Public Health Preparedness


 


Moderator                Dr. Stephen C. Redd (Centers for Disease Control and Prevention, USA) and


 


                                  Dr. Jean-Louis Excler (International Vaccine Institute)


 


 


 


16.00-16.20          Clinical Progression and Viral Load Kinetics of Middle East Respiratory Syndrome Coronavirus Infection


 


                           Prof. Myoung-don Oh, Seoul National University College of Medicine, Korea


 


 


 


16.20-16.40          Principle of MERS-CoV Infection Control: Saudi Arabia


 


                           Dr. Mark Beatty, Consultant, USA


 


 


 


16.40-17.00          Laboratory Preparedness in the Setting of an Outbreak


 


Dr. Bart Haagmans, Erasmus Medical Center, The Netherlands


 


 


 


17.00-17.20          Q&A


 


 


 


17.20-17.30          Closing Remarks


 


 


 


 


 


 


 


Acknowledgments


 


The symposium was organized by the MERS-CoV Symposium Scientific Committee: Kayvon Modjarrad, MHRP/WRAIR, USA;


 


James Hayslett, CDC/OPHPR/OD, USA; Jae-Ouk Kim, IVI; Jae Seung Yang, IVI; Ayan Dey, IVI; Florian Marks, IVI; Laura Digilio, IVI; Manki Song, IVI; Jerome Kim, IVI


 


 


 


 


 


Sponsors


 


We gratefully acknowledge Shinil and the Korea Support Committee for IVI (KSC) for their support.


 


 


 


 


 


Register at:  http://goo.gl/forms/i3Rw3HlzH9

DONATE